Use of Prescription Antiemetics Among US Commercially Insured Pregnant Patients, 2005-2019
This cohort study investigates prescription antiemetic treatment patterns considering monotherapy, switching, and combination therapy during the first trimester of pregnancy and evaluates factors associated with ondansetron use.
Authors
- Joshua David Brown (ORCID: https://orcid.org/0000-0002-2973-1021)
- Stephan Schmidt (ORCID: https://orcid.org/0000-0002-4998-1167)
- Almut G. Winterstein (ORCID: https://orcid.org/0000-0002-6518-5961)
- Sonja A. Rasmussen (ORCID: https://orcid.org/0000-0002-0574-4928)
- Judith C. Maro (ORCID: https://orcid.org/0000-0001-9900-2142)
- Thuy Nhu Thai (ORCID: https://orcid.org/0000-0003-4544-1160)
Institutions
- Center for Drug Evaluation and Research (US)
- Harvard University (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- University of Florida (US)
- Harvard Pilgrim Health Care (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-10-22
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.40414
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 0.00